hotspot -WSS

hotspot

author：focus 2025-09-30 00:37:39 - browse：17

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Advances in CAR

hotspot

entertainment

WSS

How to protect patients from sexual assault

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

My chronic pain journey would have been easier knowing 5 things % STAT

Why Novartis is changing the name of its research labs

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Listen: Biogen's potential pivot, & Illumina's next chapter

explore

hotspot

focus

23andMe had bad news about my health. I wish a person had delivered it

The 10 drugs up first for Medicare price negotiation

Supreme Court strikes down use of affirmative action

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Duchenne breakthrough therapy leaves behind pioneering families

NIH nominee Bertagnolli will get October confirmation hearing

DIEP, the 'gold standard' of breast reconstruction, is under threat

Burning questions about Delta and the next phase of the Covid pandemic

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AstraZeneca chief proposes a novel edit to the drug pricing bill

hotspot

How to protect coverage of PrEP

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Illumina names Agilent executive as new CEO

What American doctors can learn from their Israeli counterparts

Burning questions about Delta and the next phase of the Covid pandemic

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

hotspot

hotspot

entertainment

knowledge